Skip Ribbon Commands
Skip to main content

Useful Links


The eventual elimination of TB as a public health threat is a global effort that requires coordinated effort and global commitment. There are many organizations around the world working in the field of TB. We provide links to the websites of some of these research, advocacy, and implementing organizations that are making great strides in developing and advocating for new tools to combat TB.​

  • GH-VAP was created to benefit Bill & Melinda Gates Foundation (BMGF) Grantees and Partners by linking researchers with best-in-class research services to accelerate vaccine discovery and translation. Based on the successful model of CAVD (Collaboration for AIDS Vaccine Discovery), GH-VAP leverages existing infrastructure to provide broader access to select research platforms for BMGF grantees across disease areas.

  • CAVD is an international network of scientists and experts dedicated to designing a variety of novel HIV vaccine candidates and advancing the most promising candidates to clinical trials. The Bill & Melinda Gates Foundation is the largest private foundation in the world, founded by Bill and Melinda Gates. Guided by the belief that every life has equal value, the foundation works to help all people lead healthy, productive lives.

  • Aeras is a nonprofit, global biotech organization developing new tuberculosis vaccines for the world, in partnership with other biotech, pharmaceutical, and academic organizations. Aeras has an international staff of more than 100 people, with offices in the U.S., Africa, and Asia representing a critical mass of expertise in TB and vaccine development.

  • TBVI is a non-profit foundation that facilitates the discovery and development of new, safe and effective TB vaccines that are accessible and affordable for all people. As a Product Development Partnership (PDP), TBVI integrates, translates and prioritises R&D efforts to discover and develop new TB vaccines and biomarkers for global use.

  • WHO TB advances universal access to TB prevention, care and control; guides the global response to threats; and promotes innovation.

  • STOP TB is a partnership of over 1,000 international and technical organizations, government programmes, research and funding agencies, foundations, NGOs, civil society and community groups and the private sector. The Partnership’s role is whose role is to accelerate progress on access to TB diagnosis and treatment; research and development for new TB diagnostics, drugs and vaccines; and tackling drug resistant- and HIV-associated TB.

  • US CDC TB promotes health and quality of life by preventing, controlling and eventually eliminating tuberculosis from the United States, and by collaborating with other countries and international partners in controlling global tuberculosis.

  • Challenge TB runs from September 30, 2014 until September 29, 2019 and will align with the WHO post-2015 Global TB Strategy and the new United States Government TB Strategy to enhance focus on improving patient-centered quality TB services, building local capacity and the utilization of innovations and new technologies to move forward in the global fight against TB.

  • TB Alliance is developing new, affordable TB drugs that will shorten treatment time, work against drug-resistant TB, be compatible with HIV antiretrovirals and improve treatment of latent TB.

  • Global Health Technologies Coalition (GHTC) is a group of more than 25 nonprofit organizations working to increase awareness of the urgent need for technologies that save lives in the developing world.